Methylphenidate Generis 54 mg Depottablett スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

methylphenidate generis 54 mg depottablett

generis farmacêutica, sa - metylfenidathydroklorid - depottablett - 54 mg - metylfenidathydroklorid 44,28 mg aktiv substans; metylfenidathydroklorid 9,72 mg aktiv substans; laktosmonohydrat hjälpämne

Methylphenidate Generis 36 mg Depottablett スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

methylphenidate generis 36 mg depottablett

generis farmacêutica, sa - metylfenidathydroklorid - depottablett - 36 mg - metylfenidathydroklorid 29,52 mg aktiv substans; laktosmonohydrat hjälpämne; metylfenidathydroklorid 6,48 mg aktiv substans

Methylphenidate STADA 36 mg Depottablett スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

methylphenidate stada 36 mg depottablett

stada arzneimittel ag - metylfenidathydroklorid - depottablett - 36 mg - laktosmonohydrat hjälpämne; metylfenidathydroklorid 6,48 mg aktiv substans; metylfenidathydroklorid 29,52 mg aktiv substans

Methylphenidate STADA 18 mg Depottablett スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

methylphenidate stada 18 mg depottablett

stada arzneimittel ag - metylfenidathydroklorid - depottablett - 18 mg - metylfenidathydroklorid 14,76 mg aktiv substans; metylfenidathydroklorid 3,24 mg aktiv substans; laktosmonohydrat hjälpämne

Methylphenidate STADA 54 mg Depottablett スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

methylphenidate stada 54 mg depottablett

stada arzneimittel ag - metylfenidathydroklorid - depottablett - 54 mg - metylfenidathydroklorid 9,72 mg aktiv substans; laktosmonohydrat hjälpämne; metylfenidathydroklorid 44,28 mg aktiv substans

Methylphenidate STADA 27 mg Depottablett スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

methylphenidate stada 27 mg depottablett

stada arzneimittel ag - metylfenidathydroklorid - depottablett - 27 mg - laktosmonohydrat hjälpämne; metylfenidathydroklorid 4,86 mg aktiv substans; metylfenidathydroklorid 22,14 mg aktiv substans

Methylphenidate Orion 27 mg Depottablett スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

methylphenidate orion 27 mg depottablett

orion corporation - metylfenidathydroklorid - depottablett - 27 mg - metylfenidathydroklorid 22,14 mg aktiv substans; metylfenidathydroklorid 4,86 mg aktiv substans; laktosmonohydrat hjälpämne

Methylphenidate Orion 36 mg Depottablett スウェーデン - スウェーデン語 - Läkemedelsverket (Medical Products Agency)

methylphenidate orion 36 mg depottablett

orion corporation - metylfenidathydroklorid - depottablett - 36 mg - laktosmonohydrat hjälpämne; metylfenidathydroklorid 6,48 mg aktiv substans; metylfenidathydroklorid 29,52 mg aktiv substans

Carvykti 欧州連合 - スウェーデン語 - EMA (European Medicines Agency)

carvykti

janssen-cilag international nv - ciltacabtagene autoleucel - multipelt myelom - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Tecvayli 欧州連合 - スウェーデン語 - EMA (European Medicines Agency)

tecvayli

janssen-cilag international n.v. - teclistamab - multipelt myelom - antineoplastiska medel - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.